HR
ARNA

Howe & Rusling’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Howe & Rusling’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-200
Closed -$4K – 1097
2015
Q3 		$4K Buy
+200
New +$6.79K ﹤0.01% 702

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Howe & Rusling's ARNA Position: Q4 2015 in Review

Howe & Rusling sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2015, closing a stake of 200 shares — an estimated $4K sold.

Howe & Rusling first reported a position in ARNA in Q3 2015 and held it in 1 quarter. The position peaked at $4K in Q3 2015. 121 funds tracked by Wall St. Rank hold ARNA as of Q4 2015.

  • Howe & Rusling reported no remaining Arena Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Howe & Rusling sold 200 Arena Pharmaceuticals Inc shares in Q4 2015, an estimated $4K.
  • Howe & Rusling first reported a position in Arena Pharmaceuticals Inc in Q3 2015 and held it in 1 quarter.
  • Howe & Rusling's Arena Pharmaceuticals Inc position peaked at $4K in Q3 2015.
  • 121 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2015.

Based on Howe & Rusling's 13F filing for Q4 2015, filed 11 Feb 2016.